Tissue engineering by self-assembly uses the cells' secretome as a regeneration template and biological factory of trophic factors. Despite the several advantages that have been witnessed in preclinical and clinical settings, the major obstacle for wide acceptance of this technology remains the tardy extracellular matrix formation. In this study, we assessed the influence of macromolecular crowding (MMC)/excluding volume effect, a biophysical phenomenon that accelerates thermodynamic activities and biological processes by several orders of magnitude, in human corneal fibroblast (HCF) culture. Our data indicate that the addition of negatively charged galactose derivative (carrageenan) in HCF culture, even at 0.5% serum, increases by 12-fold tissue-specific matrix deposition, while maintaining physiological cell morphology and protein/gene expression. Gene analysis indicates that a glucose derivative (dextran sulfate) may drive corneal fibroblasts toward a myofibroblast lineage. Collectively, these results indicate that MMC may be suitable not only for clinical translation and commercialization of tissue engineering by self-assembly therapies, but also for the development of in vitro pathophysiology models.
Get full access to this article
View all access options for this article.
References
1.
DankersP.Y.W., HarmsenM.C., BrouwerL.A., Van LuynM.J.A., and MeijerE.W.A modular and supramolecular approach to bioactive scaffolds for tissue engineering. Nat Mater, 4, 568, 2005.
2.
MatsudaN., ShimizuT., YamatoM., and OkanoT.Tissue engineering based on cell sheet technology. Adv Mater, 19, 3089, 2007.
3.
MironovV., ViscontiR.P., KasyanovV., ForgacsG., DrakeC.J., and MarkwaldR.R.Organ printing: tissue spheroids as building blocks. Biomaterials, 30, 2164, 2009.
4.
NicholJ.W., and KhademhosseiniA.Modular tissue engineering: engineering biological tissues from the bottom up. Soft Matter, 5, 1312, 2009.
5.
JakabK., NorotteC., MargaF., MurphyK., Vunjak-NovakovicG., and ForgacsG.Tissue engineering by self-assembly and bio-printing of living cells. Biofabrication, 2, 22001, 2010.
6.
PeckM., DusserreN., McAllisterT.N., and L'HeureuxN.Tissue engineering by self-assembly. Mater Today, 14, 218, 2011.
7.
GreenH., KehindeO., and ThomasJ.Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A, 76, 5665, 1979.
L'HeureuxN., McAllisterT.N., and de la FuenteL.M.Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med, 357, 1451, 2007.
10.
NandkumarM.A., YamatoM., KushidaA., KonnoC., HiroseM., KikuchiA., and OkanoT.Two-dimensional cell sheet manipulation of heterotypically co-cultured lung cells utilizing temperature-responsive culture dishes results in long-term maintenance of differentiated epithelial cell functions. Biomaterials, 23, 1121, 2002.
11.
PirracoR.P., ObokataH., IwataT., MarquesA.P., TsunedaS., YamatoM., ReisR.L., and OkanoT.Development of osteogenic cell sheets for bone tissue engineering applications. Tissue Eng Part A, 17, 1507, 2011.
12.
OhashiK., YokoyamaT., YamatoM., KugeH., KanehiroH., TsutsumiM., AmanumaT., IwataH., YangJ., OkanoT., and NakajimaY.Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med, 13, 880, 2007.
13.
NiM., RuiY.F., TanQ., LiuY., XuL.L., ChanK.M., WangY., and LiG.Engineered scaffold-free tendon tissue produced by tendon-derived stem cells. Biomaterials, 34, 2024, 2013.
14.
NishidaK., YamatoM., HayashidaY., WatanabeK., YamamotoK., AdachiE., NagaiS., KikuchiA., MaedaN., WatanabeH., OkanoT., and TanoY.Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med, 351, 1187, 2004.
15.
VranaN.E., BuillesN., JustinV., BednarzJ., PellegriniG., FerrariB., DamourO., HulmesD.J.S., and HasirciV.Development of a reconstructed cornea from collagen–chondroitin sulfate foams and human cell cultures. Invest Ophthalmol Vis Sci, 49, 5325, 2008.
16.
RenR., HutcheonA.E.K., GuoX.Q., SaeidiN., MelottiS.A., RubertiJ.W., ZieskeJ.D., and Trinkaus-RandallV.Human primary corneal fibroblasts synthesize and deposit proteoglycans in long-term 3-D cultures. Dev Dyn, 237, 2705, 2008.
17.
CampisiJ., and d'Adda di FagagnaF.Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol, 8, 729, 2007.
18.
BeltramiA.P., CesselliD., and BeltramiC.A.Stem cell senescence and regenerative paradigms. Clin Pharmacol Ther, 91, 21, 2012.
HolstJ., WatsonS., LordM.S., EamegdoolS.S., BaxD.V., Nivison-SmithL.B., KondyurinA., MaL., OberhauserA.F., WeissA.S., and RaskoJ.E.Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol, 28, 1123, 2010.
21.
MohyeldinA., Garzon-MuvdiT., and Quinones-HinojosaA.Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell, 7, 150, 2010.
22.
EdalatF., BaeH., ManoucheriS., ChaJ., and KhademhosseiniA.Engineering approaches toward deconstructing and controlling the stem cell environment. Ann Biomed Eng, 40, 1301, 2012.
23.
CigogniniD., LomasA., KumarP., SatyamA., EnglishA., AzeemA., PanditA., and ZeugolisD.Engineering in vitro microenvironments for cell based therapies and drug discovery. Drug Discov Today, 18, 1099, 2013.
24.
PancholiS., TulloA., KhaliqA., ForemanD., and BoultonM.The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol, 236, 1, 1998.
25.
JesterJ.V., and Ho-ChangJ.Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res, 77, 581, 2003.
26.
YoshidaS., ShimmuraS., ShimazakiJ., ShinozakiN., and TsubotaK.Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci, 46, 1653, 2005.
27.
KawakitaT., EspanaE.M., HeH., SmiddyR., ParelJ.-M., LiuC.-Y., and TsengS.C.G.Preservation and expansion of the primate keratocyte phenotype by downregulating TGF-β signaling in a low-calcium, serum-free medium. Invest Ophthalmol Vis Sci, 47, 1918, 2006.
28.
KimA., LakshmanN., KaramichosD., and Matthew PetrollW.Growth factor regulation of corneal keratocyte differentiation and migration in compressed collagen matrices. Invest Ophthalmol Vis Sci, 51, 864, 2010.
29.
LakshmanN., and PetrollW.Growth factor regulation of corneal keratocyte mechanical phenotypes in 3-D collagen matrices. Invest Ophthalmol Vis Sci, 53, 1077, 2012.
30.
ThompsonR., BoraasL., SowderM., BechtelM., and OrwinE.Three-dimensional cell culture environment promotes partial recovery of the native corneal keratocyte phenotype from a subcultured population. Tissue Eng Part A, 19, 1564, 2013.
31.
EtheredgeL., KaneB.P., ValkovN., AdamsS., BirkD.E., and HassellJ.R.Enhanced cell accumulation and collagen processing by keratocytes cultured under agarose and in media containing IGF-I, TGF-[beta] or PDGF. Matrix Biol, 29, 519, 2010.
32.
ZimmermanS.B., and HarrisonB.Macromolecular crowding increases binding of DNA polymerase to DNA: an adaptive effect. Proc Natl Acad Sci U S A, 84, 1871, 1987.
33.
MintonA.P., ColclasureG.C., and ParkerJ.C.Model for the role of macromolecular crowding in regulation of cellular volume. Proc Natl Acad Sci U S A, 89, 10504, 1992.
34.
ZimmermanS.B., and MintonA.P.Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu Rev Biophys Biomol Struct, 22, 27, 1993.
35.
van den BergB., EllisR.J., and DobsonC.M.Effects of macromolecular crowding on protein folding and aggregation. EMBO J, 18, 6927, 1999.
36.
EllisR.J.Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struct Biol, 11, 114, 2001.
37.
EllisR., and MintonA.Cell biology: join the crowd. Nature, 425, 27, 2003.
38.
LareuR.R., SubramhanyaK.H., PengY., BennyP., ChenC., WangZ., RajagopalanR., and RaghunathM.Collagen matrix deposition is dramatically enhanced in vitro when crowded with charged macromolecules: the biological relevance of the excluded volume effect. FEBS Lett, 581, 2709, 2007.
39.
LareuR.R., ArsiantiI., SubramhanyaH.K., YanxianP., and RaghunathM.In vitro enhancement of collagen matrix formation and crosslinking for applications in tissue engineering: a preliminary study. Tissue Eng Part A, 13, 385, 2007.
40.
SatyamA., KumarP., FanX., GorelovA., RochevY., JoshiL., PeinadoH., LydenD., ThomasB., RodriguezB., RaghunathM., PanditA., and ZeugolisD.Macromolecular crowding meets tissue engineering by self-assembly: a paradigm shift in regenerative medicine. Adv Mater, 26, 3024, 2014.
41.
BerryhillB.L., KaderR., KaneB., BirkD.E., FengJ., and HassellJ.R.Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest Ophthalmol Vis Sci, 43, 3416, 2002.
42.
TallhedenT., van der LeeJ., BrantsingC., MånssonJ., Sjögren-JanssonE., and LindahlA.Human serum for culture of articular chondrocytes. Cell Transplant, 14, 469, 2005.
43.
AngL., TanD., SeahC., and BeuermanR.The use of human serum in supporting the in vitro and in vivo proliferation of human conjunctival epithelial cells. Br J Ophthalmol, 89, 748, 2005.
44.
MannelloF., and TontiG.Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold!. Stem Cells, 25, 1603, 2007.
45.
TateishiK., AndoW., HiguchiC., HartD., HashimotoJ., NakataK., YoshikawaH., and NakamuraN.Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplant, 17, 549, 2008.
46.
MazlyzamA., AminuddinB., SaimL., and RuszymahB.Human serum is an advantageous supplement for human dermal fibroblast expansion: clinical implications for tissue engineering of skin. Arch Med Res, 39, 743, 2008.
47.
LindroosB., AhoK., KuokkanenH., RätyS., HuhtalaH., LemponenR., Yli-HarjaO., SuuronenR., and MiettinenS.Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng Part A, 16, 2281, 2010.
48.
AldahmashA., Haack-SørensenM., Al-NbaheenM., HarknessL., AbdallahB., and KassemM.Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev, 7, 860, 2011.
49.
FanaliG., di MasiA., TrezzaV., MarinoM., FasanoM., and AscenziP.Human serum albumin: from bench to bedside. Mol Aspects Med, 33, 209, 2012.
50.
DreherL., Elvers-HornungS., BrinkmannI., HuckV., HenschlerR., GloeT., KlüterH., and BiebackK.Cultivation in human serum reduces adipose tissue-derived mesenchymal stromal cell adhesion to laminin and endothelium and reduces capillary entrapment. Stem Cells Dev, 22, 791, 2013.
51.
BirkD.E., FitchJ.M., BabiarzJ.P., and LinsenmayerT.F.Collagen type I and type V are present in the same fibril in the avian corneal stroma. J Cell Biol, 106, 999, 1988.
52.
RuggieroF., BurillonC., and GarroneR.Human corneal fibrillogenesis. Collagen V structural analysis and fibrillar assembly by stromal fibroblasts in culture. Invest Ophthalmol Vis Sci, 37, 1749, 1996.
53.
SunM., ChenS., AdamsS., FlorerJ., LiuH., KaoW., WenstrupR., and BirkD.Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model. J Cell Sci, 124, 4096, 2011.
54.
TotiP., TosiG., TraversiC., SchürfeldK., CardoneC., and CaporossiA.CD-34 stromal expression pattern in normal and altered human corneas. Ophthalmology, 109, 1167, 2002.
55.
EspanaE., KawakitaT., LiuC., and TsengS.CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci, 45, 2985, 2004.
56.
IshizakiM., ZhuG., HasebaT., ShaferS., and KaoW.Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci, 34, 3320, 1993.
57.
JesterJ.V., PetrollW.M., BarryP.A., and CavanaghH.D.Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci, 36, 809, 1995.
58.
SriramS., RobinsonP., PiL., LewinA., and SchultzG.Triple combination of siRNAs targeting TGFβ1, TGFβR2, and CTGF enhances reduction of collagen I and smooth muscle actin in corneal fibroblasts. Invest Ophthalmol Vis Sci, 54, 8214, 2013.
59.
ChenC., PengY., WangZ., FishP., KaarJ., KoepselR., RussellA., LareuR., and RaghunathM.The scar-in-a-jar: studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. Br J Pharmacol, 158, 1196, 2009.
60.
MusselmannK., AlexandrouB., KaneB., and HassellJ.R.Maintenance of the keratocyte phenotype during cell proliferation stimulated by insulin. J Biol Chem, 280, 32634, 2005.
61.
FunderburghJ.L., MannM.M., and FunderburghM.L.Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem, 278, 45629, 2003.
62.
KawakitaT., EspanaE.M., HeH., HorniaA., YehL.-K., OuyangJ., LiuC.-Y., and TsengS.C.G.Keratocan expression of murine keratocytes is maintained on amniotic membrane by down-regulating transforming growth factor-β signaling. J Biol Chem, 280, 27085, 2005.
63.
GuerrieroE., ChenJ., SadoY., MohanR., WilsonS., FunderburghJ., and SundarrajN.Loss of alpha3(IV) collagen expression associated with corneal keratocyte activation. Invest Ophthalmol Vis Sci, 48, 627, 2007.
64.
BuillesN., BechetoilleN., JustinV., DucerfA., AuxenfansC., BurillonC., SergentM., and DamourO.Development of an optimised culture medium for keratocytes in monolayer. Biomed Mater Eng, 16, 95, 2006.
65.
PerrellaG., BrusiniP., SpelatR., HossainP., HopkinsonA., and DuaH.Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes. Br J Ophthalmol, 91, 94, 2007.
66.
WuJ., DuY., MannM., YangE., FunderburghJ., and WagnerW.Bioengineering organized, multilamellar human corneal stromal tissue by growth factor supplementation on highly aligned synthetic substrates. Tissue Eng Part A, 19, 2063, 2013.
67.
KaramichosD., RichC.B., ZareianR., HutcheonA.E.K., RubertiJ.W., Trinkaus-RandallV., and ZieskeJ.D.TGF-β3 stimulates stromal matrix assembly by human corneal keratocyte-like cells. Invest Ophthalmol Vis Sci, 54, 6612, 2013.
68.
DoortyK., GolubevaT., GorelovA., RochevY., AllenL., DawsonK., GallagherW., and KeenanA.Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells. Cardiovasc Pathol, 12, 105, 2003.
69.
GilcreestV., CarrollW., RochevY., BluteI., DawsonK., and GorelovA.Thermoresponsive poly(N-isopropylacrylamide) copolymers: contact angles and surface energies of polymer films. Langmuir, 20, 10138, 2004.
70.
MoranM.T., CarrollW.M., SeleznevaI., GorelovA., and RochevY.Cell growth and detachment from protein-coated PNIPAAm-based copolymers. J Biomed Mater Res Part A, 81, 870, 2007.
71.
SzczupakB., RyderA., TogashiD., KlymchenkoA., RochevY., GorelovA., and GlynnT.Polarity assessment of thermoresponsive poly(NIPAM-co-NtBA) copolymer films using fluorescence methods. J Fluoresc, 20, 719, 2010.
72.
GuoX., HutcheonA.E.K., MelottiS.A., ZieskeJ.D., Trinkaus-RandallV., and RubertiJ.W.Morphologic characterization of organized extracellular matrix deposition by ascorbic acid-stimulated human corneal fibroblasts. Invest Ophthalmol Vis Sci, 48, 4050, 2007.
73.
DuY., SundarRajN., FunderburghM.L., HarveyS.A., BirkD.E., and FunderburghJ.L.Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Invest Ophthalmol Vis Sci, 48, 5038, 2007.
74.
ProulxS., UwamaliyaJ.D., CarrierP., DeschambeaultA., AudetC., GiassonC.J., GuérinS.L., AugerF.A., and GermainL.Reconstruction of a human cornea by the self-assembly approach of tissue engineering using the three native cell types. Mol Vis, 16, 2192, 2010.
75.
GrobeG.M., and ReichlS.Characterization of vitamin C-induced cell sheets formed from primary and immortalized human corneal stromal cells for tissue engineering applications. Cells Tissues Organs, 197, 283, 2013.
76.
ShimizuT., SekineH., YangJ., IsoiY., YamatoM., KikuchiA., KobayashiE., and OkanoT.Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J, 20, 708, 2006.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
